Eldon C. Mayer III, EVP & Chief Commercial Officer at RIGEL PHARMACEUTICALS INC (RIGL), bought 100,000 shares at $2.82 ($282K) on 2018-08-23, disclosed to the SEC on 2018-08-27.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| EIGR | SELL | 2022-01-11 | $8K | — | Filing → |
| EIGR | SELL | 2021-01-11 | $20K | — | Filing → |
| EIGR | BUY | 2020-01-30 | $68K | — | Filing → |